BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2013
View Archived Issues
Pfizer develops novel ADCs targeting IL-13RA2
Read More
MRX-34 shows promising results in rodent and nonhuman primate models
Read More
Genentech presents preliminary safety and pharmacokinetic data for MPDL-3280A
Read More
Neuralgene set to begin animal studies of ALS gene therapy
Read More
BAY-94-9343 demonstrates clinical activity in patients with solid tumors
Read More
Matrix-Bio and Quest Diagnostics sign metabolomic biomarker licensing agreement
Read More
Novartis presents new data for their ALK inhibitor LDK-378
Read More
Oncos Therapeutics discloses novel cancer vaccines
Read More
Acorda Therapeutics reports phase II Ampyra study results in patients with post-stroke deficits
Read More
Hypermethylation of the HOXA4 gene as a potential biomarker in CML
Read More
FDA sets PDUFA action date for PA-21
Read More
New agents for tuberculosis prepared by CSIR
Read More
Merck & Co. presents new ROMK blockers for cardiovascular disorders
Read More
Phase I study of Mologen's MGN-1404 approved by Paul-Ehrlich Institute
Read More
Novel MAbs targeting human GITR prepared by Sanofi
Read More
Eli Lilly patents novel antibodies for lipoprotein disorders
Read More
Discovery Labs receives correspondence from FDA regarding updated Surfaxin specifications
Read More
Asmacure commences phase I/II trial of dry powder for inhalation of lead compound
Read More
New HIF-PH inhibitors synthesized by Merck & Co.
Read More
NeurOp receives second half of NIH grant for schizophrenia research
Read More
Board recommends continuation of enobosarm phase III trials
Read More
Merrimack updates progress of phase II HER2-negative breast cancer study
Read More
NeuroDerm studies levodopa/carbidopa patch pump in phase IIa study
Read More
Santaris and Bristol-Myers Squibb establish strategic alliance
Read More
BHR Pharma updates progress of SyNAPSe study in severe traumatic brain injury
Read More
Topline results from first pivotal COPD study of fixed-dose aclidinium/formoterol
Read More
